Join
Live feed
·
INSIDERFilingvia Quantisnow
TransCode Therapeutics Inc. logo

Fitzgerald Thomas A bought $25,168 worth of shares (49,350 units at $0.51), increasing direct ownership by 708% to 56,318 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RNAZ· TransCode Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNAZ (TransCode Therapeutics Inc.) and more on Quantisnow.